These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 2521060)
41. Fast and sensitive LC-MS/MS assay for quantification of nortriptyline and its active metabolites E- and Z-10-hydroxynortriptyline in human plasma. Bonke G; Jensen BP Bioanalysis; 2010 Sep; 2(9):1553-60. PubMed ID: 21083284 [TBL] [Abstract][Full Text] [Related]
42. Nortriptyline in depressed patients with left ventricular impairment. Roose SP; Glassman AH; Giardina EG; Johnson LL; Walsh BT; Woodring S; Bigger JT JAMA; 1986 Dec; 256(23):3253-7. PubMed ID: 3783871 [TBL] [Abstract][Full Text] [Related]
43. Enantioselective formation and disposition of (E)- and (Z)-10-hydroxynortriptyline. Nusser E; Nill K; Breyer-Pfaff U Drug Metab Dispos; 1988; 16(3):509-11. PubMed ID: 2900750 [No Abstract] [Full Text] [Related]
44. Nortriptyline pharmacokinetics and plasma levels: implications for clinical practice. Rubin EH; Biggs JT; Preskorn SH J Clin Psychiatry; 1985 Oct; 46(10):418-24. PubMed ID: 3900052 [TBL] [Abstract][Full Text] [Related]
45. Nortriptyline in the hospitalized elderly: tolerance and side effect reduction. Rosen J; Sweet R; Pollock BG; Mulsant BH Psychopharmacol Bull; 1993; 29(2):327-31. PubMed ID: 8290682 [TBL] [Abstract][Full Text] [Related]
46. Antidepressive effect and pharmacokinetics of amitriptyline with consideration of unbound drug and 10-hydroxynortriptyline plasma levels. Breyer-Pfaff U; Gaertner HJ; Kreuter F; Scharek G; Brinkschulte M; Wiatr R Psychopharmacology (Berl); 1982; 76(3):240-4. PubMed ID: 6808544 [TBL] [Abstract][Full Text] [Related]
47. Baseline and 2- to 3-year follow-up characteristics of placebo-washout responders from the nortriptyline study of depressed 6- to 12-year-olds. Geller B; Fox LW; Cooper TB; Garrity K J Am Acad Child Adolesc Psychiatry; 1992 Jul; 31(4):622-8. PubMed ID: 1644724 [TBL] [Abstract][Full Text] [Related]
48. Inhibition of CYP2D6 with low dose (5 mg) paroxetine in patients with high 10-hydroxynortriptyline serum levels-A prospective pharmacokinetic study. Jessurun NT; Vermeulen Windsant A; Mikes O; van Puijenbroek EP; van Marum RJ; Grootens K; Derijks HJ Br J Clin Pharmacol; 2021 Mar; 87(3):1529-1532. PubMed ID: 32621544 [TBL] [Abstract][Full Text] [Related]
49. Double-blind, placebo-controlled study of nortriptyline in depressed children using a "fixed plasma level" design. Geller B; Cooper TB; McCombs HG; Graham D; Wells J Psychopharmacol Bull; 1989; 25(1):101-8. PubMed ID: 2672066 [No Abstract] [Full Text] [Related]
50. Prediction of steady-state plasma levels of amitriptyline and nortriptyline from a single dose 24 hr. level in depressed patients. Brunswick DJ; Amsterdam J; Schless A; Rothbart M; Sandler K; Mendels J J Clin Psychiatry; 1980 Oct; 41(10):337-40. PubMed ID: 7430077 [TBL] [Abstract][Full Text] [Related]
51. Drug treatment of depression in frail elderly nursing home residents. Streim JE; Oslin DW; Katz IR; Smith BD; DiFilippo S; Cooper TB; Ten Have T Am J Geriatr Psychiatry; 2000; 8(2):150-9. PubMed ID: 10804076 [TBL] [Abstract][Full Text] [Related]
52. Molecular structure and dynamics of the four 10-hydroxynortriptyline isomers. Heimstad E; Edvardsen O; Dahl SG Neuropsychopharmacology; 1992 May; 6(3):137-44. PubMed ID: 1599604 [TBL] [Abstract][Full Text] [Related]
53. Comparative efficacy and safety of nortriptyline and fluoxetine in the treatment of major depression: a clinical study. Fabre LF; Scharf MB; Itil TM J Clin Psychiatry; 1991 Jun; 52 Suppl():62-7. PubMed ID: 2050651 [TBL] [Abstract][Full Text] [Related]
55. Simulated home treatment of depression with nortriptyline. Peabody C; Van Norman J; Hollister L; Warner D Prog Neuropsychopharmacol Biol Psychiatry; 1991; 15(1):63-70. PubMed ID: 2008540 [TBL] [Abstract][Full Text] [Related]
56. An outpatient evaluation of phenelzine and imipramine. Davidson J; Raft D; Pelton S J Clin Psychiatry; 1987 Apr; 48(4):143-6. PubMed ID: 3549705 [TBL] [Abstract][Full Text] [Related]
58. Acute open-trial nortriptyline therapy of bereavement-related depression in late life. Pasternak RE; Reynolds CF; Schlernitzauer M; Hoch CC; Buysse DJ; Houck PR; Perel JM J Clin Psychiatry; 1991 Jul; 52(7):307-10. PubMed ID: 2071562 [TBL] [Abstract][Full Text] [Related]
59. Combined pharmacotherapy and psychotherapy in the acute and continuation treatment of elderly patients with recurrent major depression: a preliminary report. Reynolds CF; Frank E; Perel JM; Imber SD; Cornes C; Morycz RK; Mazumdar S; Miller MD; Pollock BG; Rifai AH Am J Psychiatry; 1992 Dec; 149(12):1687-92. PubMed ID: 1443245 [TBL] [Abstract][Full Text] [Related]
60. Treatment of nortriptyline's side effects in elderly patients: a double-blind study of bethanechol. Rosen J; Pollock BG; Altieri LP; Jonas EA Am J Psychiatry; 1993 Aug; 150(8):1249-51. PubMed ID: 8101048 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]